Can You Be Born With Vitiligo? Rarity and Genetics

Yes, you can be born with vitiligo, but it is extremely rare. Vitiligo overwhelmingly appears later in life, most often between the ages of 20 and 30. As of the most recent literature reviews, only seven published case reports of true congenital vitiligo (vitiligo present at birth) have been documented worldwide. So while it’s technically possible, it’s far more likely that a baby born with white patches on the skin has a different condition entirely.

How Rare Is Congenital Vitiligo?

Vitiligo affects roughly 1 to 2 percent of the global population, with no particular differences by sex, race, or region. Nearly all of those cases develop during adolescence or adulthood. The handful of confirmed cases in newborns are so scarce that researchers still lack solid data on how congenital vitiligo develops or how it behaves over time compared to the typical form. Some dermatologists consider the very existence of congenital vitiligo controversial, since the autoimmune process behind the condition usually takes time to destroy pigment-producing cells.

The Genetic Link Between Parents and Children

Vitiligo is not directly inherited like eye color. It involves a complex mix of genetic susceptibility and immune system triggers. If you have vitiligo, the chance that your child will develop it at some point in their life is about 5 percent, or roughly 1 in 20. That’s five times higher than the general population risk, but it still means the large majority of children with a vitiligo-affected parent will never develop the condition themselves. And even within that 5 percent, almost none would show signs at birth.

White Patches at Birth Are Usually Something Else

When a newborn has clearly depigmented skin, the most common explanation is not vitiligo. Several other conditions cause white or light patches from birth, and they’re much more likely in infants:

  • Piebaldism: A genetic condition present from birth that causes stable, well-defined white patches. About 80 to 90 percent of people with piebaldism also have a white forelock (a patch of white hair at the front of the scalp). Unlike vitiligo, piebaldism doesn’t spread or change much over time.
  • Waardenburg syndrome: Another genetic condition that can cause skin depigmentation and a white forelock, but also comes with features like widely spaced eyes, different-colored irises, or hearing loss. About 45 percent of people with Waardenburg syndrome have a white forelock, and 30 percent have skin depigmentation.
  • Nevus depigmentosus: A birthmark that appears as a lighter patch of skin. It’s stable from birth and doesn’t expand the way vitiligo does.
  • Tuberous sclerosis: A genetic condition that can produce ash-leaf shaped light spots on the skin, along with other developmental features.

The key distinction is that vitiligo is an autoimmune process where the body’s immune system attacks its own pigment cells over time. The conditions above involve pigment cells that never developed normally in the first place or that produce less pigment due to a genetic blueprint, not immune destruction. This is why doctors approach white patches in a newborn very differently than white patches that appear in a teenager or adult.

How Doctors Tell the Difference

When a baby has depigmented skin, one of the first tools a dermatologist uses is a Wood’s lamp, which is essentially a handheld ultraviolet light. Under this lamp, true vitiligo patches glow a bright blue-white color, making them easy to distinguish from other types of lighter skin. The lamp also helps define the exact borders of any patches, which can be harder to see under normal lighting, especially in fair-skinned infants.

Beyond the lamp exam, doctors look at the pattern and location of the patches, whether a white forelock is present, and whether the baby has any other features like hearing differences or unusual eye spacing. A family history of vitiligo or other autoimmune conditions (like thyroid disease) would raise the suspicion for vitiligo specifically, but the diagnosis in a newborn still requires careful exclusion of the more common congenital causes.

When Vitiligo Appears in Early Childhood

While birth-onset vitiligo is vanishingly rare, vitiligo during infancy and early childhood is more commonly reported, though still unusual. Most pediatric vitiligo shows up after the first year of life. One form called segmental vitiligo tends to appear earlier than the more common nonsegmental type. Segmental vitiligo is likely caused by a genetic change that happens during embryonic development (called somatic mosaicism), which may explain why it tends to affect just one area of the body and stabilizes relatively quickly rather than continuing to spread.

Nonsegmental vitiligo, the more common form, involves the immune system gradually destroying pigment cells across different areas. This type can be unpredictable. It may stay limited to small patches for years or spread more broadly. In children, the face, neck, and hands are frequently the first areas affected.

Treatment Options for Young Children

For children whose vitiligo covers less than about 20 percent of their body and isn’t spreading rapidly, topical treatments are the standard first approach. Low to moderate strength steroid creams have decades of use behind them and can help restore some pigment, but long-term use in children carries real concerns: skin thinning, stretch marks, and in severe cases, effects on growth and hormone balance.

A newer class of topical creams (calcineurin inhibitors) produces similar results with fewer skin-thinning side effects, making them especially appealing for sensitive areas like the face. However, these are not recommended for children under 2 years old. For very young infants with confirmed congenital vitiligo, treatment options are limited, and many dermatologists take a watch-and-wait approach since the condition isn’t painful or physically harmful.

Light-based therapies, which are commonly used in adults, are more restricted in children. Oral light therapy is not used in children under 12, while topical versions can be considered for children 2 and older with limited disease. For older children and teens whose vitiligo has stabilized, pigment cell transplantation is sometimes an option, particularly for segmental vitiligo that isn’t responding to other treatments.